Literature DB >> 27818608

Phytosterols from Spondias mombin Linn with Antimycobacterial Activities.

J A O Olugbuyiro1, J O Moody2, M T Hamann3.   

Abstract

The growing problems of tuberculosis have led to the search for new anti-Mtb agents from higher plants. The stem bark of Spondias mombin was evaluated for its in vitro activity against Mycobacterium tuberculosis (H37Rv strain). Bioassay-guided fractionation of the methanol extract was carried out by Vacuum Liquid Chromatography (VLC) on Silica gel (230-400 mesh) and purification was done using HPLC and TLC. In vitro antimycobacterial susceptibility was performed by a fluorometric microplate alamar blue assay (MABA) and percentage mycobacterial inhibition was calculated. The structures of the isolated compounds were established by spectroscopic analysis. The active VLC fraction exhibited 91% inhibition against M. tuberculosis H37Rv at a concentration of 40 μg/mL. The HPLC fraction SMi-15 containing compounds 1 and 2 showed 92.8% inhibition against M. tuberculosis. Two new antimycobacterial phytosterols were isolated from the stem bark of S. mombin and the structures were identified as mombintane I (1) and mombintane II (2). The stem bark extractives of S. mombin contain antitubercular principles of the class phytosterol and support an important potential of triterpenoids.

Entities:  

Keywords:  Mycobacterium tuberculosis; Spondias mombin; antimycobacterial; mombintane I; mombintane II

Year:  2013        PMID: 27818608      PMCID: PMC5096588     

Source DB:  PubMed          Journal:  Afr J Biomed Res        ISSN: 1119-5096


  7 in total

1.  Evaluation of the wound-healing activity of selected traditional medicinal plants from Perú.

Authors:  L F Villegas; I D Fernández; H Maldonado; R Torres; A Zavaleta; A J Vaisberg; G B Hammond
Journal:  J Ethnopharmacol       Date:  1997-02       Impact factor: 4.360

2.  Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay.

Authors:  S G Franzblau; R S Witzig; J C McLaughlin; P Torres; G Madico; A Hernandez; M T Degnan; M B Cook; V K Quenzer; R M Ferguson; R H Gilman
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

3.  Sedative, antiepileptic and antipsychotic effects of Spondias mombin L. (Anacardiaceae) in mice and rats.

Authors:  Abiodun O Ayoka; Rufus O Akomolafe; Ezekiel O Iwalewa; Moses A Akanmu; Otas E Ukponmwan
Journal:  J Ethnopharmacol       Date:  2005-09-26       Impact factor: 4.360

4.  Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium.

Authors:  L Collins; S G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

5.  SB-202742, a novel beta-lactamase inhibitor isolated from Spondias mombin.

Authors:  N J Coates; M L Gilpin; M N Gwynn; D E Lewis; P H Milner; S R Spear; J W Tyler
Journal:  J Nat Prod       Date:  1994-05       Impact factor: 4.050

6.  Antibacterial and molluscicidal phenolic acids from Spondias mombin.

Authors:  J Corthout; L Pieters; M Claeys; S Geerts; D Vanden Berghe; A Vlietinck
Journal:  Planta Med       Date:  1994-10       Impact factor: 3.352

7.  New cucurbitane triterpenoids and steroidal glycoside from Momordica charantia.

Authors:  Jie-Qing Liu; Jian-Chao Chen; Cui-Fang Wang; Ming-Hua Qiu
Journal:  Molecules       Date:  2009-11-25       Impact factor: 4.411

  7 in total
  5 in total

1.  Anticholinesterase constituents from the leaves of Spondias mombin L. (Anacardiaceae).

Authors:  Taiwo Olayemi Elufioye; Efere M Obuotor; Joseph M Agbedahunsi; Saburi A Adesanya
Journal:  Biologics       Date:  2017-08-02

Review 2.  Genus Spondias: A Phytochemical and Pharmacological Review.

Authors:  Salma Sameh; Eman Al-Sayed; Rola M Labib; Abdel Nasser Singab
Journal:  Evid Based Complement Alternat Med       Date:  2018-02-12       Impact factor: 2.629

3.  Brassicasterol with Dual Anti-Infective Properties against HSV-1 and Mycobacterium tuberculosis, and Cardiovascular Protective Effect: Nonclinical In Vitro and In Silico Assessments.

Authors:  Sherif T S Hassan
Journal:  Biomedicines       Date:  2020-05-24

Review 4.  A review on anti-peptic ulcer activities of medicinal plants used in the formulation of Enterica, Dyspepsia and NPK 500 capsules.

Authors:  Doris Kumadoh; Mary-Ann Archer; Genevieve N Yeboah; Michael O Kyene; Mavis Boakye-Yiadom; Ofosua Adi-Dako; Christina Osei-Asare; Emmanuel Adase; Alfred A Appiah; Susana O Mintah
Journal:  Heliyon       Date:  2021-11-29

Review 5.  Antimicrobial activity of Nigerian medicinal plants.

Authors:  Madubuike Umunna Anyanwu; Rosemary Chinazam Okoye
Journal:  J Intercult Ethnopharmacol       Date:  2017-02-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.